Global Health in the Crossfire: The Unseen Cost of US Funding Retreat on Africa's Ebola Crisis

The specter of Ebola is back, not with the dramatic headlines of 2014, but with a stealthier, more insidious spread across Central and East Africa. What began as isolated clusters in the Democratic Republic of Congo (DRC) and Uganda in late 2025 has now metastasized into a full-blown public health emergency, one that is testing the resilience of Africa’s health systems and exposing the fragility of global preparedness. As of mid-May 2026, the World Health Organization (WHO) has recorded 530 confirmed cases and 134 deaths, with a case fatality rate ranging between 25% and 50%—a grim reminder of the virus’s lethality. Yet behind these sobering statistics lies a deeper crisis: the deliberate dismantling of America’s once-robust global health infrastructure has left the continent dangerously exposed, transforming what should be a manageable outbreak into a potential regional catastrophe.

The Ebola strain now circulating, Bundibugyo, is less well-known than its infamous cousin, Ebola Zaire, but it is no less deadly. First identified in Uganda in 2007, Bundibugyo has re-emerged with a vengeance, exploiting gaps in surveillance, laboratory capacity, and rapid response—gaps that have widened dramatically in recent years due to policy shifts in Washington. While the world’s attention has been diverted by geopolitical tensions and economic instability, a quieter unraveling has been underway in the corridors of global health funding. The United States, long the linchpin of pandemic preparedness and response in Africa, has drastically reduced its investment in programs that once served as the first line of defense against emerging pathogens.

This article examines not just the immediate toll of the Ebola outbreak, but the systemic erosion of health security in Africa catalyzed by US policy decisions. It explores how the withdrawal of American leadership has created a vacuum that no other nation or multilateral body has fully filled, and what this means for the future of global health diplomacy. Through data, expert testimony, and regional analysis, we uncover the human and economic costs of this retreat—and why the consequences may extend far beyond the borders of the DRC and Uganda.

The Collapse of the US Health Safety Net in Africa

The dismantling of America’s global health apparatus did not happen overnight. It was the culmination of years of policy decisions, culminating in the 2025 launch of the Department of Government Efficiency (DOGE), a controversial initiative aimed at streamlining federal operations by eliminating redundant agencies. Among the hardest hit was the United States Agency for International Development (USAID), whose Office of Global Health and key programs like the President’s Emergency Plan for AIDS Relief (PEPFAR) and the Global Health Security Agenda (GHSA) saw their budgets slashed by over 60% in a single fiscal year.

According to internal USAID documents obtained by *The Lancet Global Health* in early 2026, the cuts directly affected 18 countries in sub-Saharan Africa, including high-risk zones like eastern DRC, where Ebola has become endemic. The reductions eliminated funding for 42 field offices, reduced surveillance teams by 70%, and terminated partnerships with 150 local health organizations that provided critical on-the-ground support. Dr. Fatoumata Binta, a senior epidemiologist in Dakar, Senegal, who previously worked with USAID-supported rapid response teams, described the impact as “catastrophic.” “We used to have teams that could deploy within 24 hours,” she said. “Now, even getting a single test kit to a remote health center can take weeks.”

The Centers for Disease Control and Prevention (CDC), another cornerstone of global health security, saw its global health security budget reduced from $150 million in 2024 to just $45 million in 2026. This has led to the closure of regional CDC hubs in Nairobi, Kinshasa, and Dakar—hubs that once coordinated outbreak detection, data sharing, and emergency response across 40 African nations. The closure of the Nairobi hub alone removed real-time genomic sequencing capabilities for pathogens like Ebola, forcing African labs to rely on slower, less reliable methods.

These cuts were justified under the banner of “fiscal responsibility,” but public health experts argue they reflect a dangerous miscalculation of risk. The US had long positioned itself as a global leader in pandemic preparedness, investing over $10 billion annually in global health security through 2024. By 2026, that investment had plummeted to under $3 billion—a drop that coincides with a 400% increase in reported zoonotic disease outbreaks worldwide, according to the WHO’s *World Health Statistics Report 2026*.

The Ebola Outbreak as a Symptom of Systemic Failure

The current Ebola outbreak in the DRC’s North Kivu and Ituri provinces, and neighboring Uganda’s Bundibugyo District, is not an isolated incident. It is a symptom of a broader failure in health system resilience—a failure that has been decades in the making but accelerated by recent policy choices.

The DRC has battled Ebola for over a decade, with the 2018–2020 outbreak in eastern DRC becoming the second-deadliest in history, claiming 2,287 lives. That crisis was contained, in part, by a robust international response led by the US CDC and WHO, which deployed rapid diagnostic tools, mobile labs, and community engagement teams. But in 2025, as US funding evaporated, those tools were withdrawn. By the time the current outbreak was detected in November 2025, local health workers were already reporting shortages of personal protective equipment (PPE), rapid diagnostic tests, and trained personnel.

Amadou Bocoum, DRC country director for the anti-poverty nonprofit CARE, told *Connect Quest* that health centers in Beni and Butembo were operating with “less than 30% of the supplies they had in 2024.” “We are not able to react immediately,” he said. “The system is fragmented, underfunded, and burning out.” His testimony is echoed by data from the DRC Ministry of Health, which shows that the average time from symptom onset to isolation increased from 3.2 days in 2024 to 7.8 days in early 2026—a delay that significantly raises transmission risk.

The situation in Uganda is equally dire. Bundibugyo virus, named after the district where it was first identified, has a case fatality rate of up to 50%. The Ugandan Ministry of Health reported 89 confirmed cases and 32 deaths by May 2026, but experts suspect underreporting due to limited testing capacity. The closure of the CDC-supported Uganda Virus Research Institute’s (UVRI) field station in Bundibugyo in late 2025 removed the only lab in the region capable of confirming Ebola within 24 hours. Now, samples must be sent to Entebbe—a journey of 200 km—that can take up to 72 hours, delaying contact tracing and quarantine efforts.

These delays are not just administrative inconveniences; they are life-and-death matters. Ebola’s average incubation period is 8–10 days, but patients can be infectious for up to three weeks before symptoms appear. Each day of delay in detection increases the number of secondary cases exponentially. A modeling study published in *Nature Medicine* in March 2026 estimated that without immediate scaling of response efforts, the current outbreak could spiral into 2,000 cases by the end of 2026—more than four times the current number.

The Ripple Effect: Regional and Global Consequences

The impact of America’s retreat from global health security extends far beyond the immediate outbreak zones. It has created a domino effect that threatens regional stability and global health security.

First, it has eroded trust in public health systems. In both DRC and Uganda, communities that once cooperated with health workers during outbreaks now resist contact tracing and vaccination campaigns due to years of underinvestment and perceived abandonment. A 2025 survey by the Africa Centres for Disease Control and Prevention (Africa CDC) found that trust in government health services dropped by 45% in regions affected by US funding cuts. This distrust has fueled misinformation, with rumors that Ebola is a bioweapon or a government conspiracy spreading rapidly on social media, further complicating containment efforts.

Second, the withdrawal has weakened regional coordination mechanisms. The East African Community (EAC) and the Southern African Development Community (SADC) have historically relied on US-supported surveillance networks to detect cross-border outbreaks. With these networks dismantled, the risk of unchecked spread to neighboring countries like Rwanda, Burundi, and South Sudan has risen sharply. The WHO’s Regional Office for Africa has warned that without urgent intervention, the outbreak could become “the first multi-country Ebola epidemic in East Africa in over a decade.”

Third, the economic fallout is already being felt. The World Bank estimates that the DRC’s GDP could shrink by 1.2% in 2026 due to the outbreak, with tourism and cross-border trade in eastern DRC declining by up to 30%. Uganda, which relies heavily on agricultural exports to Europe and the Middle East, has seen shipping delays as ports in Mombasa and Dar es Salaam impose stricter health checks. The Africa Development Bank has projected that the total economic cost of the outbreak could exceed $2.3 billion by the end of 2026—funds that could have been invested in health systems, education, and infrastructure.

Perhaps most alarmingly, the US retreat has emboldened other nations to follow suit. China, which has been expanding its health diplomacy in Africa through initiatives like the Africa CDC’s “Health Silk Road,” has increased its presence in Uganda and DRC—but its model prioritizes infrastructure over long-term capacity building. Meanwhile, Russia has leveraged its Sputnik V vaccine diplomacy, offering doses to African nations in exchange for political influence. While these engagements are not inherently negative, they lack the integrated, community-based approach that the US once provided—one that combined medical expertise, local partnerships, and sustainable funding.

Can Africa Fill the Void?

In the absence of US leadership, Africa has begun to take charge of its own health security—but the road is long and uneven. The Africa CDC, established in 2017, has emerged as the continent’s primary defense against outbreaks. With a budget of $150 million in 2026—up from $50 million in 2024—it has launched the “Africa CDC Pathogen Genomics Initiative,” which aims to establish sequencing labs in every region. Yet even this effort is hamstrung by limited resources. As of May 2026, only 12 of Africa’s 54 countries have operational genomic sequencing labs, compared to 38 in 2024.

The African Union has also stepped up with the “Africa Health Strategy 2026–2030,” which includes a $500 million fund for outbreak response. But this fund, while commendable, is a fraction of the $2 billion that USAID alone once committed annually to global health security in Africa. Moreover, disbursement is slow due to bureaucratic hurdles and reliance on voluntary contributions from member states, many of which are grappling with their own economic crises.

Civil society organizations have tried to fill the gap. Médecins Sans Frontières (MSF) has increased its presence in North Kivu, deploying mobile clinics and community health workers. But MSF’s resources are finite, and its focus on emergency response leaves little room for long-term capacity building. Similarly, the African Field Epidemiology Network (AFENET), which trains disease detectives across the continent, has seen its US funding dry up, forcing it to rely on European and Japanese donors—who, while generous, do not match the scale of US investment.

The result is a patchwork of responses: some areas are well-defended, others abandoned. In South Sudan, for example, the closure of the US-supported CDC field office in Juba in 2025 left the country with no dedicated Ebola surveillance team. When a suspected case was reported in January 2026, it took 12 days to confirm—by which time the patient had traveled to Uganda, potentially exposing dozens of people.

The Way Forward: Rebuilding Before the Next Crisis

The current Ebola outbreak is not just a health crisis; it is a geopolitical and economic warning sign. It demonstrates what happens when short-term fiscal decisions collide with long-term global security imperatives. The US, despite its retreat, remains the world’s largest economy and a key player in global health. Its absence is not just felt in Africa—it is felt in Southeast Asia, where dengue outbreaks are surging, and in Latin America, where Zika and chikungunya continue to resurface.

To reverse course, several steps are urgently needed:

1. Restore US Funding to Critical Programs: The Global Health Security Agenda, which once received $500 million annually, must be reinstated with a minimum of $300 million in 2027. This funding should prioritize strengthening lab networks, training local epidemiologists, and deploying rapid response teams. The CDC’s global health security budget should be restored to at least $120 million, with a focus on rebuilding regional hubs in Nairobi, Kinshasa, and Dakar.

2. Reform the DOGE Initiative: The Department of Government Efficiency must recognize that global health is not “redundant”—it is foundational. A 2026 GAO report found that every $1 invested in pandemic preparedness saves $15 in outbreak response costs. DOGE should be restructured to protect, not dismantle, health security investments.

3. Strengthen Africa’s Health Architecture: The Africa CDC needs sustainable, predictable funding—not just emergency pledges. The $500 million Africa Health Strategy fund should be converted into a permanent endowment, with contributions tied to GDP growth rather than voluntary donations. Regional bodies like the EAC and SADC must also integrate health security into their trade and security agreements.

4. Foster Public-Private Partnerships: Technology companies, particularly those in diagnostics and telemedicine, can play a critical role. For example, diagnostics firm Cepheid’s GeneXpert platform, which can detect Ebola in under 90 minutes, has seen its US government contracts canceled. Reinstating these contracts and expanding access to such technologies could revolutionize outbreak detection.

5. Rebuild Trust Through Community Engagement: The failure of health systems is not just a funding issue—it is a trust issue. Community leaders, religious figures, and local media must be engaged as partners in outbreak response. In DRC, traditional healers have often been sidelined; integrating them into surveillance networks could bridge the gap between formal and informal health systems.

Conclusion: A Call to Action Before It’s Too Late

The Ebola outbreak in Central and East Africa is a bellwether—a sign that the world’s defenses against pandemics are eroding just when they are needed most. It is a crisis manufactured not by a virus, but by policy choices that prioritize immediate savings over long-term security. The human cost is already staggering: 134 lives lost, families shattered, communities traumatized. But the greater danger lies in what comes next—a world where outbreaks spiral unchecked, where diseases cross borders with impunity, and where the next pandemic is not a question of if, but when.

America’s retreat from global health is not just Africa’s problem; it is the world’s problem. The interconnectedness of our economies, our travel networks, and our shared ecosystems means that a health crisis in Kinshasa or Kampala can quickly become a crisis in Kansas City or Kyoto. The US cannot isolate itself from global health threats,